Bendamustine Hydrochloride - NDC Database
16 records found
Page:
10019-079 Dec 15, 2022
Bendamustine Hydrochloride 100 mg Intravenous Injection by Baxter Healthcare Corporation
Bendamustine Hydrochloride 100 mg Intravenous Injection by Baxter Healthcare Corporation
16729-250 Dec 07, 2022
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
16729-251 Dec 07, 2022
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
42367-520 May 15, 2018
Bendamustine Hydrochloride 100 mg Intravenous Injection by Eagle Pharmaceuticals, Inc
Bendamustine Hydrochloride 100 mg Intravenous Injection by Eagle Pharmaceuticals, Inc
55150-391 Jun 05, 2023
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
55150-392 Jun 05, 2023
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
60505-6095 Jun 19, 2023
Bendamustine Hydrochloride 25 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
Bendamustine Hydrochloride 25 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
60505-6096 Jun 19, 2023
Bendamustine Hydrochloride 100 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
Bendamustine Hydrochloride 100 mg Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
60505-6228 Apr 26, 2023
Bendamustine Hydrochloride 25 mg/ml Intravenous Injection, Solution by Apotex Corp
Bendamustine Hydrochloride 25 mg/ml Intravenous Injection, Solution by Apotex Corp
67457-325 Apr 26, 2018
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
67457-326 Apr 26, 2018
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
68001-571 Sep 15, 2023
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
68001-572 Sep 15, 2023
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
71288-102 Jun 05, 2023
Bendamustine 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
Bendamustine 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
71288-103 Jun 05, 2023
Bendamustine 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
Bendamustine 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.